Published September 30, 2022 | Version https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue9,Article133.pdf
Journal article Open

Biochemical Evaluation of Creatinine and Urea in Patients with Renal Failure Undergoing Hemodialysis in Tertiary Care Hospital at Bhagalpur District, Bihar

  • 1. JR 3rd Year, Department of Biochemistry, Jawaharlal Nehru Medical College, Bhagalpur, Bihar
  • 2. Associate Professor, Department of Biochemistry, Jawaharlal Nehru Medical College, Bhagalpur, Bihar

Description

One of the slowest developing kidney disorders, renal failure is typically marked by decreased glomerular filtration rate (GRF). Hemodialysis is used as a replacement therapy for renal failure and entails the elimination of the body’s excess toxic fluids and toxic metabolic waste products. In light of this context, the current effort concentrated on evaluating and correlating the importance of several biochemical indicators in blood serum from renal failure patients before and after dialysis. Serum creatinine and urea are two of the many biochemical factors found in blood that are emerging as more accurate indicators of renal failure. Thus, samples from 50 patients with renal failure before and after hemodialysis were included in the analytical part of this investigation to determine the prevalence of creatinine and urea levels. For the detection of creatinine and urea concentrations in human serum, a colorimetrical method utilising a fully automated analyzer was chosen.  The concentration of urea was found to be lower than that of creatinine, and the mean values of these two components in the post-dialysis group were lower than those in the pre-dialysis group. Before hemodialysis, the incidence of serum creatinine and urea was noticeably high, and it considerably decreased following hemodialysis. The study found a statistically significant correlation between the levels of urea and creatinine in pre- and post-dialysis blood serum samples from patients with renal failure.

 

 

 

Abstract (English)

One of the slowest developing kidney disorders, renal failure is typically marked by decreased glomerular filtration rate (GRF). Hemodialysis is used as a replacement therapy for renal failure and entails the elimination of the body’s excess toxic fluids and toxic metabolic waste products. In light of this context, the current effort concentrated on evaluating and correlating the importance of several biochemical indicators in blood serum from renal failure patients before and after dialysis. Serum creatinine and urea are two of the many biochemical factors found in blood that are emerging as more accurate indicators of renal failure. Thus, samples from 50 patients with renal failure before and after hemodialysis were included in the analytical part of this investigation to determine the prevalence of creatinine and urea levels. For the detection of creatinine and urea concentrations in human serum, a colorimetrical method utilising a fully automated analyzer was chosen.  The concentration of urea was found to be lower than that of creatinine, and the mean values of these two components in the post-dialysis group were lower than those in the pre-dialysis group. Before hemodialysis, the incidence of serum creatinine and urea was noticeably high, and it considerably decreased following hemodialysis. The study found a statistically significant correlation between the levels of urea and creatinine in pre- and post-dialysis blood serum samples from patients with renal failure.

 

 

 

Files

IJPCR,Vol14,Issue9,Article133.pdf

Files (278.5 kB)

Name Size Download all
md5:be058026e1f430419e786319936b29dd
278.5 kB Preview Download

Additional details

Dates

Accepted
2022-09-25

References

  • 1. Draczevski L, Teixeira ML. Avaliação do perfil bioquímico e parâmetros hematológicos em pacientes submetidos à hemodiálise. Rev Saud Pesq. 2011; 4:15-22. 2. Mascha V, Rashmi K, Priyadarshi SS, et al. Comparing age wise reference intervals for serum creatinine concentration in a "reality check" of the recommended cut-off. Indian J Clin Biochem. 2006; 21:90-94. 3. Eduardo OC, Kaue A, Idania AA, et al. Influence of hemodialysis on the plasma concentration of adenosine deaminase in patients with chronic kidney disease. J Bras Patol Med Lab. 2015; 51:153-157. 4. Rusul Arif AA, Haider S. A study of some biochemical changes in patients with chronic renal failure undergoing hemodialysis. Int J Curr Microbiol App Sci. 2014;3: 581-586. 5. Noor ul A, Raja Tahir M, Javaid Asad M, et al. Evaluating urea and creatinine levels in chronic renal failure pre and post dialysis: A prospective study. J Cardiovasc Disease. 2014:2:1-5. 6. Azra K. Estimation of blood urea (BUN) and serum creatinine level in patients of renal disorder. J Fundam Appl Sci. 2014; 4:199-202. 7. Raghunandan S, Deepak Kumar S, Ram Lakhan M. Effectiveness of SelfInstructional Module (SIM) on knowledge regarding home care management among patients with chronic renal failure undergoing haemodialysis at selected hospital of Punjab. IOSR J Nurs Health Sci. 2016; 5:20-31. 8. Wendy E, Bloembergen DC, Friedrich K, et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int.1996; 50:557-565. 9. Toma I, Marinho JS, Limeres JJ, et al. Changes in salivary composition in patients with renal failure. Arch Oral Biol. 2008;53: 528–532. 10. Renuga DTS, Gunasekaran S, Wesley HJ, et al. Analysis on renal failure patient's blood samples: Characterization and efficacy study. Indian J Sci Technol. 2009; 2:46-50. 11. Kunitoshi I, Yoshiharu I, Koshiro F. Risk factors of endstage renal disease and serum creatinine in a communitybased mass screening. Kidney Int. 1997; 51:850-854. 12. William R, Clark K, Bruce A, et al. Quantification of creatinine kinetic parameters in patients with acute renal failure. Kidney Int. 1998; 54:554-560. 13. Mohamd SMA, Muna AB, Leela Babiker M, et al. Hematological changes post- hemo and peritoneal dialysis among renal failure patients in Sudan. Saudi J Kidney Dis Transpl. 2008; 19:274-279. 14. Yassin MM, Abdel Monem HL, Ahmed JAT, et al. Homocystiene and hematological indices in Hemodialysis Patients. Ibnosina J Med Biomed Sci. 2014; 6:173-179. 15. Saba ZA, Layla AM, Dhafer SK. Study of some biochemical changes in serum of patients with chronic renal failure. Irq Nat J Chem. 2012; 4:270-280. 16. Akbar D, Mohammad M, Shadi T, et al. Anemia and thrombocytopenia in acute and chronic renal failure. Int J Hematol Oncol Stem Cell Res. 2013; 7:34-39. 17. Ossman DH, Marouf BH, Ameen KH. Effect of extracorporeal unfractionated heparin on hematological and electrolyte markers in hemodialyzed patients. JPPA. 2014; 4:431-439. 18. Rock RC, Walker WG, Hennings CD. Nitrogen metabolites and renal function. In: Tietz NW, ed. Fundamentals of Clinical Chemistry, 3rd ed. Philadelphia: WB Saunders. 1987;669-704. 19. Attika K, Lubna Z. Effect of hemodialysis on mean prothrombin time and activated partial thromboplastin time in patients of end stage renal disease. Journal RMC. 2015; 19:247-249. 20. Khaled MD, Faiz A, Abdelgader AT, et al. Effect of haemodialysis on some metabolic products of CKD patients in Libya. WJPPS. 2015; 4:45-54. 21. Felix C, Stefan CV, Dan R, et al. Hemodialysis- induced electrolyte variation ( serum calcium, magnesium, and bicarbonate) and intradialytic heart rhythm disorders. Int J Bioflux Society. 2014; 6:11-14. 22. Gonella GM. Effect of dialysis on certain biochemical parameters in chronic renal failure patients. International Journal of Contemporary Medical Research. 2016;3: 2454-7379. 23. Merzah KS, Hasson SF. The biochemical changes in patients with chronic renal failure: Int J Pharma Med Bio Sci. 2015; 4:75-79.